Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): A practice review
Y Fu, EJ Chapman, AC Boland… - Palliative …, 2022 - journals.sagepub.com
Background: Patients with chronic obstructive pulmonary disease (COPD) face limited
treatment options and inadequate access to palliative care. Aim: To provide a pragmatic …
treatment options and inadequate access to palliative care. Aim: To provide a pragmatic …
The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic …
K Tanimura, S Sato, Y Fujita… - Chronic Respiratory …, 2023 - journals.sagepub.com
Background The rationale for additional treatment with short-acting bronchodilators
combined with long-acting bronchodilators for patients with chronic obstructive pulmonary …
combined with long-acting bronchodilators for patients with chronic obstructive pulmonary …
Inhaled corticosteroids with combination inhaled long‐acting beta2‐agonists and long‐acting muscarinic antagonists for chronic obstructive pulmonary disease
JAE Walters, EH Walters - Cochrane Database of Systematic …, 2023 - cochranelibrary.com
Background Management of chronic obstructive pulmonary disease (COPD) commonly
involves a combination of long‐acting bronchodilators including beta2‐agonists (LABA) and …
involves a combination of long‐acting bronchodilators including beta2‐agonists (LABA) and …